Deutsche Bank Lifts Target on Achillion Pharmaceuticals (ACHN), Sees 60% Upside
Tweet Send to a Friend
Deutsche Bank boosted its price target on Buy-rated Achillion Pharmaceuticals (NASDAQ: ACHN) price target from $12 to $17, suggesting 60 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
